Chantal Babb de Villiers
banner
chantalresearch.bsky.social
Chantal Babb de Villiers
@chantalresearch.bsky.social
Researcher with a special interest in cancer, genetics, epidemiology and public health. Views are my own. Posts are not an endorsement.
Reposted by Chantal Babb de Villiers
Absolutely thrilled to announce the launch of ARTIC2 - a £5.5M 5 year project funded by @wellcometrust.bsky.social to build on the ARTIC approach of low-cost, globally accessible genome sequencing for surveillance of outbreaks, epidemics and endemic diseases: www.birmingham.ac.uk/news/2025/am...
Ambitious project to develop low-cost genome sequencing for pathogens known and unknown - University of Birmingham
Project will build on research that helped diagnostic labs to adopt sequencing capacity for COVID-19 and permit characterisation of future infectious threats
www.birmingham.ac.uk
May 22, 2025 at 10:57 AM
Reposted by Chantal Babb de Villiers
The most recent validation of the PREDICT breast prognostic model published today (v3).
doi.org/10.6004/jncc...
Work in collaboration with Yi-Wen Hsiao, Pei-Chen Peng and Gordon Wishart.

If any philanthropists out there want to cover to costs of maintaining this valuable clinical tool please DM me.
Assessing the Performance of the PREDICT Breast Version 3.0 Prognostic Tool in Patients With Breast Cancer in the United States
Background: PREDICT Breast version 3 (v3) is the latest updated prognostication tool, developed using data from approximately 35,000 women diagnosed with breast cancer between 2000 and 2018 in the Uni...
doi.org
May 13, 2025 at 8:27 PM
Thank you #MEMTAB2025! Enjoying this on the train home. It was great to talk about the latest on methods for evaluation of models, tests and biomarkers. The continuous pursuit of accurate and reliable health tests involves many dedicated to developing and refining methods.
Coming to MEMTAB?
We've got a Cadbury treat waiting for you 😋
#memtab2025
May 1, 2025 at 4:40 PM
Reposted by Chantal Babb de Villiers
The CONSORT and SPIRIT statements for randomized trials have been updated for 2025 and published in JAMA, with a new focus on open science principles and guidance on trial registration, data access, and conflict of interest reporting.

➡ CONSORT 2025: ja.ma/3Yyu0Hh
➡ SPIRIT 2025: ja.ma/3YjFfn8
April 29, 2025 at 2:00 PM
Reposted by Chantal Babb de Villiers
👀 New blog👀

Health and climate change are inextricably linked, yet policy development tends to focus on one or the other. A joined up approach is necessary to create effective, sustainable improvements in environment-related health interventions.
Read on... www.phgfoundation.org/blog/data-th...
Data: the catalyst for health and climate action  - PHG Foundation
Both health and climate change are highly complex issues,with numerous interdependencies. Integrating policy is challenging but essential.
www.phgfoundation.org
March 3, 2025 at 11:47 AM
Reposted by Chantal Babb de Villiers
😍 We all love a one-page summary, so here's one for our strategic direction to accompany @peterfrmills.bsky.social blog. www.phgfoundation.org/blog/policy-...
We're keen to hear the ambitions and views of others working at the science/health/policy interface, comments and DMs welcome.
February 28, 2025 at 9:05 AM
Reposted by Chantal Babb de Villiers
Last month we launched our Precision Medicine report in Parliament, calling for personalised prevention to be at the heart of care to ease NHS pressures.

Read our joint report with @phgfoundation.bsky.social to find out more ➡️ https://buff.ly/4axn5TE
February 13, 2025 at 1:36 PM
🌟 New Blog🌟
Pharmacogenomics is leading the way in how genomic information is being used in healthcare and could significantly impact how genomics is integrated across the entire healthcare system. www.phgfoundation.org/blog/pioneer...
Pioneering change: how pharmacogenomics is shaping healthcare - PHG Foundation
Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug prescribing
www.phgfoundation.org
February 10, 2025 at 2:56 PM
Exciting News in Gene Therapy! 
NICE has approved the use of gene therapy exa-cel for treating sickle cell disease! This groundbreaking development offers new hope for patients and marks a significant milestone in medical science. 🧬✨
www.phgfoundation.org/news/worlds-...
World’s first gene editing therapy now in the UK for sickle cell disease - PHG Foundation
The approval by NICE of Exa-cel provides new hope for people living with sickle cell disease.
www.phgfoundation.org
February 3, 2025 at 3:54 PM
In London at AWS offices hearing how Genomics England is developing a clinical genomics platform
January 28, 2025 at 1:55 PM
Reposted by Chantal Babb de Villiers
Delighted to be at the launch of the #PhysiologyPassport report at House of Commons today with @physoc.bsky.social. A great discussion on the opportunities that arise with personalised prevention
January 14, 2025 at 9:58 PM
Reposted by Chantal Babb de Villiers
My story is here, do read it (writing that is my day job 😅): www.science.org/content/arti...
Why hasn’t the bird flu pandemic started?
Some scientists examining mutations found in H5N1 viruses fear major outbreak is imminent but others says pathogen remains unpredictable
www.science.org
December 6, 2024 at 2:06 PM